Voglibose 0.2 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg GLIMITERIS TRIO 0.2 GLIMITERIS TRIO is oral antidiabetic medications, but all salts belong to different drug classes and work through different mechanisms to control blood sugar levels in individuals with type 2 diabetes. When used in GLIMITERIS TRIO , they provide a comprehensive approach to managing diabetes. Voglibose Class: Alpha-glucosidase inhibitor. Mechanism of Action: Voglibose works by slowing down the digestion and absorption of carbohydrates in the small intestine. This leads to a more gradual increase in blood sugar levels after meals. Usage: Often used in combination with other antidiabetic medications, Voglibose is particularly effective in controlling postprandial (after-meal) blood glucose levels. Glimepiride Class: Sulfonylurea. Mechanism of Action: Glimepiride stimulates the pancreas to produce more insulin. Insulin is a hormone that helps lower blood glucose levels by allowing sugar (glucose) to enter cells. Usage: Typically prescribed when diet and exercise alone do not provide adequate blood sugar control. It is often used in conjunction with metformin or other diabetes medications. Side Effects: The most common side effect is hypoglycemia (low blood sugar). Other side effects may include weight gain and gastrointestinal disturbances. Metformin Hydrochloride Class: Biguanide. Mechanism of Action: Metformin decreases glucose production in the liver, decreases glucose absorption in the intestines, and improves insulin sensitivity, thereby increasing peripheral glucose uptake and utilization. Usage: Often the first medication prescribed for type 2 diabetes; it’s effective in improving glycemic control without causing weight gain and has a low risk of hypoglycemia. Side Effects: Gastrointestinal symptoms like diarrhea and nausea are common but often diminish over time. Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 5 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us. For further information please contact: info@sterispharma.com order now: https://www.sterisonline.com/product/glimiteris-trio-0-2-134376